Testing an artificial intelligence algorithm for detecting newborn hip dysplasia on ultrasound scans

ISRCTN ISRCTN49436239
DOI https://doi.org/10.1186/ISRCTN49436239
IRAS number 316325
Secondary identifying numbers IRAS 316325
Submission date
18/06/2024
Registration date
19/06/2024
Last edited
19/06/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
The study aims to evaluate the impact of an AI algorithm on the diagnostic accuracy, speed and confidence of healthcare professionals in diagnosing developmental dysplasia of the hip (DDH) on ultrasound scans. The study will involve 10 readers, who will interpret 70 ultrasound scans of baby hips, with and without AI assistance. The scans will include 35 normal and 35 abnormal cases, all of which have been obtained during routine screening in the NHS. The study will also assess the stand-alone performance of the AI algorithm.

Who can participate?
Consultants/attendings (specialising in Paediatric Orthopaedic Surgery) and registrars/residents. Specialist physiotherapists who take part in hip screening as part of their clinical practice.

What does the study involve?
10 readers of varying seniority will be recruited from eight NHS Trusts. This will include five consultant/attending surgeons, four registrars/residents and one specialist physiotherapist. Readers will interpret each scan with and without AI assistance, with an intervening 2-week "washout" period. Each reader will mark seven anatomical points (landmarks, used to determine the diagnosis) in each scan. They will provide their overall confidence score (scale of 1 to 5, 1 = not confident, 5 = very confident) in annotating all the points apart from the labrum.
Using a panel of two paediatric orthopaedic surgeons who specialise in DDH as ground truth, the stand-alone performance of the AI algorithm will assessed, alongside its impact on reader’s accuracy, mean review time per scan and self-reported diagnostic confidence.

What are the possible benefits and risks of participating?
The results may show the utility of the AI algorithm as an assistive diagnostic tool. There are no risks of participating.

Where is the study run from?
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford (UK)

When is the study starting and how long is it expected to run for?
February 2024 to January 2025

Who is funding the study?
National Institute of Health and Care Research (NIHR) (UK)

Who is the main contact?
Mr Abhinav Singh, Abhinav.singh@ndorms.ox.ac.uk

Contact information

Mr Abhinav Singh
Public, Scientific, Principal Investigator

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
University of Oxford
Botnar Research Centre
Old Road
Oxford
OX3 7LD
United Kingdom

ORCiD logoORCID ID 0000-0002-7329-6792
Phone +44 (0)1865227374
Email Abhinav.singh@ndorms.ox.ac.uk

Study information

Study designRetrospective multicentre and multireader observational cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Medical and other records, University/medical school/dental school
Study typeDiagnostic, Safety, Efficacy
Scientific titleDeveloping and testing computer-assisted diagnostic tools for screening of developmental dysplasia of the hip in newborns: a multi-reader multi-case study
Study acronymDeTeCT DDH
Study hypothesisAn assistive AI algorithm can improve the diagnostic accuracy, speed and self-reported confidence of clinicians in diagnosing developmental dysplasia of the hip (DDH) on ultrasound scans.
Ethics approval(s)Ethics approval not required
Ethics approval additional informationApproved 14/03/2023, Health Research Authority (2 Redman Place, Stratford, London, E20 1JQ, UK; +44 (0)2071048000; approvals@hra.nhs.uk), ref: 23/HRA/0966

REC approval was waived for the collection of a retrospective fully anonymised dataset. Ethical approval is not required for the multi-reader multi-case study of healthcare professionals.
ConditionDevelopmental dysplasia of the hip in newborns, diagnosed by ultrasound scan
InterventionA retrospective dataset of 70 newborn ultrasound scans will be compiled to include 35 normal and 35 abnormal (dysplastic [25]/dislocated [10]) hips. The case balance is intended to better mimic clinical practice whilst still being statistically powered to detect a suspected difference in accuracy.

10 readers of varying seniority will be recruited from eight NHS Trusts. This will include five consultant/attending orthopaedic surgeons, four orthopaedic registrars/residents and one specialist physiotherapist. Readers will interpret each scan with and without AI assistance in two different sessions. There will be an intervening 2-week "washout" period to minimise reader memory of the reviewed scans.

Each reader will mark seven anatomical points (landmarks) used to determine the diagnosis on each scan. They will provide their overall confidence score (scale of 1 to 5, 1= not confident, 5= very confident) in annotating all the points apart from the labrum. Using a panel of two paediatric orthopaedic surgeons who specialise in DDH as ground truth (reference standard), the stand-alone performance of the AI algorithm will assessed, alongside its impact on the reader’s accuracy, mean review time per scan and self-reported diagnostic confidence. Subgroup analysis will be performed by the seniority of the reader.
Intervention typeOther
Primary outcome measureReader and AI algorithm performance will be evaluated as sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and Area Under Receiver Operating Characteristic Curve (AUC). Where the hip is abnormal on the ultrasound and readers correctly identify this classification as abnormal, it will be counted as a true positive, an incorrect diagnosis of normal by the reader will be a false negative. Where the hip is normal on the ultrasound, its correct classification by the reader will be a true negative and an incorrect classification will be a false positive.

The performance measures listed above will be compared for each reader with and without AI assistance. The performance of the AI algorithm alone will also be evaluated as a comparative measure.
Secondary outcome measuresReader speed will be evaluated as the mean review time per scan, with and without AI assistance. Reader confidence will be evaluated via a self-reported score (scale of 1 to 5, 1= not confident to 5 = fully confident), with and without AI assistance.
Overall study start date01/02/2024
Overall study end date31/01/2025

Eligibility

Participant type(s)Health professional
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants10
Total final enrolment10
Participant inclusion criteriaConsultants/attendings (specialising in Paediatric Orthopaedic Surgery) and registrars/residents. Specialist physiotherapists who take part in hip screening as part of their clinical practice.
Participant exclusion criteriaAny healthcare professional who does not review newborn hip ultrasound scans (either autonomously or under direct supervision) in their clinical practice
Recruitment start date01/03/2024
Recruitment end date31/05/2024

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

University of Oxford
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Botnar Research Centre
Old Road
Oxford
OX3 7LD
United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton General Hospital
Tremona Road
Southampton
SO16 6YD
United Kingdom
Norfolk and Norwich University Hospitals NHS Foundation Trust
Colney Lane
Colney
Norwich
NR4 7UY
United Kingdom
St George's University Hospitals NHS Foundation Trust
Blackshaw Road
London
SW17 0QT
United Kingdom
Royal National Orthopaedic Hospital NHS Trust
Brockley Hill
Stanmore
HA7 4LP
United Kingdom
Mid and South Essex NHS Foundation Trust
Prittlewell Chase
Westcliff-on-sea
SS0 0RY
United Kingdom
The Hillingdon Hospitals NHS Foundation Trust
Pield Heath Road
Uxbridge
UB8 3NN
United Kingdom
Imperial College Heathcare NHS Trust
The Bays
South Wharf Road
London
W2 1NY
United Kingdom
Epsom and St Helier University Hospitals NHS Trust
St Helier Hospital
Wrythe Lane
Carshalton
SM5 1AA
United Kingdom
Alder Hey Children's NHS Foundation Trust
Alder Hey Hospital
Eaton Road
West Derby
Liverpool
L12 2AP
United Kingdom

Sponsor information

University of Oxford
University/education

Research Governance, Ethics & Assurance
Boundary Brook House
Churchill Drive
Oxford
OX3 7GB
England
United Kingdom

Phone +44 (0)1865616480
Email RGEA.Sponsor@admin.ox.ac.uk
Website http://www.ox.ac.uk/
ROR logo "ROR" https://ror.org/052gg0110

Funders

Funder type

Government

National Institute for Health and Care Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom
InnovateUK
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date31/12/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication

Editorial Notes

18/06/2024: Study's existence confirmed by the HRA.